Thursday, 29 June 2017

Australia News

  • Prana completes phase II trial with PBT2

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013

    Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients with early to mid-stage Huntington disease. The company expects to anno...Read more

  • Research at Peter Mac proves Cylene drug's efficacy

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2012

    Singapore: Cylene Pharmaceuticals' research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia, have established, for the first time, that RNA Polymerase...Read more

  • Indian researcher named Woman of the Year in NSW

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2015

    Singapore: Dr Minoti Apte, a 56-year-old pancreatic researcher from India, has been named as the New South Wales 'Woman of the Year' 2015 for her excellent contributions to medical research...Read more

  • Insulin sensitizer to treat diabetes

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2012

    While pharmaceutical companies worldwide are looking for newer and safer insulin sensitizers to treat diabetes, Australia-based Verva Pharmaceuticals is working on a product candidate that ...Read more

  • BioSpectrum announces the hits and misses of 2013

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2014

    Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

  • Cellmid gets positive data in midkine study

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013

    Singapore: Cellmid has completed its first in-life diabetic nephropathy study with the company's anti-midkine antibodies (MKAb) in a mouse model of the disease. Two of Cellmid's proprietar...Read more

  • Paradigm gets US patent for bone marrow drug

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015

    Singapore: Australia based Paradigm Biopharmaceuticals has been granted a patent by United States Patent and Trademark Office (USPTO) to use the drug Pentosan Polysulphate Sodium (PPS) for ...Read more

  • China's Yabao pharma inks deal with Australian University

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2015

    Singapore: China's leading pharmaceutical firm Yabao Pharmaceutical has inked a pact with the University of South Australia, to develop new treatments for cancer.Under the terms of the deal...Read more

  • Queensland health officials fear measles outbreak

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014

    Singapore: With rising measles cases in Queensland, Australian health authorities fear a severe outbreak, as 41 cases have been reported so far in the country. The health officials said tha...Read more

  • Australian tropical research receives $15.4 mn boost

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2015

    Singapore: In a bid to foster the burgeoning tropical medicine sector in the country, the Australian government has announced funding assistance of $15.4 million to further bolster and acce...Read more

  • Bionomics to initiate trial for antibody targeting cancer stem cell

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 31 Aug, 2015

    Singapore: Bionomics, Australia based biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous syst...Read more

  • Aussie cell generation technology gets US patent

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 13 May, 2015

    Singapore: Australia based Avita Medical, a regenerative medicine company specializing in the treatment of wounds and skin defects, has recieved US patent for its method of making and using...Read more

  • ResMed to sell sleep technology in UK

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2015

    Singapore: Australian respiratory technology company Rhinomed has formed a sales agreement with global sleep technology firm, ResMed, to distribute and sell Mute snoring reduction and sleep...Read more

  • Biocryst licenses flu drug to CSL in a $45 million deal

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2015

    Singapore: Biocryst Pharmaceuticals has inked a $45 million deal with Australia's CSL licensing the rights to its influenza drug (permavir) to CSL. The deal will help Biocryst focus entirel...Read more

  • Australian instrumental in merging Asian science academies

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2012

    Singapore: Science in Asia will be more visible and effective under a merger between the two groupings of Asian science academies, facilitated over several years with leadership from the Au...Read more

  • Telstra health expands Asia presence

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015

    Singapore: Australia's largest telecommunication and technology company, Telstra health, announced several key contract wins and implementations of hospital electronic medical record system...Read more

  • Telstra acquires UK-based healthcare firm

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 27 Mar, 2015

    Singapore: Australia-based Telstra healthcare has recently acquired a UK-based health analytics company, Dr Foster in a deal estimated to be worth between $40 million to $50 million. In add...Read more

  • A re-think on site staff competency training required

    Australia |  Opinion | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013

    When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rather than the conduct of drug trials, is usually the main preoccupation...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls